Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by groundhemlockon May 01, 2019 11:00pm
132 Views
Post# 29698598

RE:RE:RE:Did TLT screw shareholders AGAIN?

RE:RE:RE:Did TLT screw shareholders AGAIN?
Menoalittle, my opinion, based on the P.P Jan 2019 and exercised warrants until April 12, the company should have enough money and time ( I estimate 6 months). Many P.P.'s will be required for phase 2. In the interim, I expect many medical conferences , slow applications with documents to proceed etc. To proceed with Phase 2 which will require money and time (est. 3 years) P.P.'s will be required. If big Pharma felt this was truly a winner, they would have invested in-directly already by now. -no need for a JV. Let the "phase 2" work its way thru by public funding. In the meantime, the company is setting up the required documents/notices for share expansions.
Bullboard Posts